<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>LA053189-0085</title>
	</head>
	<body>
		<main>
			<p><P> May 31, 1989, Wednesday, Home Edition  </P> <P> BRIEFLY  </P> <P> Anti-Cancer Drug Backed: Cetus Corp.'s anti-cancer drug Proleukin interleukin-2  has been recommended for approval by the European Economic Community's  committee for proprietary medicinal products. The drug is used in treatment of  advanced kidney cancer. The role of the committee, which meets in Brussels on a  regular basis, is to act as a centralized body for review of applications for  approval of biotech and high-tech drugs and to issue an opinion regarding drug  approval. The company said it also applied in November for marketing approval  of Proleukin with the U.S. Food and Drug Administration.  </P></p>
		</main>
</body></html>
            